ERNAErnexa Therapeutics Inc.
Earnings
When Ernexa Therapeutics Inc. reports, what it reported each quarter, and how the stock took the results.
65 quarters. Jun 30, 2010 to Jun 30, 2026. USD.
Next results · Q3 2026Projected
Nov 12, after the close
Thu, Nov 12, 2026in 11 days
Projected from its last 8 releases. The company has not named the day yet.
- Quarter
- Q3 2026 · Ended Sep 30, 2026
- 10-Q window
- Nov 3 – 16
Read against Q3 2025
The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.
- Revenue
- —
- Revenue, change from a year earlier: Q4 2024 n/m, Q3 2024 +854.9%, Q2 2024 n/m, Q1 2024 n/m
- Net income
- -$1.24M
- Net income, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m, Q3 2025 n/m
- EPS
- -$0.15
- EPS, change from a year earlier: Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m, Q2 2025 n/m
Latest results
- Revenue
- —
- —
- Net income
- -$4.01M
- N/M
- EPS
- -$3.40
- N/M
- Revenue
- —
- —
- Net income
- -$5.51M
- N/M
- EPS
- -$6.95
- N/M
- Revenue
- —
- —
- Net income
- -$1.50M
- N/M
- EPS
- —
- —
- Revenue
- —
- —
- Net income
- -$1.24M
- N/M
- EPS
- -$0.15
- N/M
All quarters
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Move | Source trail |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | ||||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 6, 2026 | 37 d | 10-Q | — | — | -$3.40 | 3.4% | |
| Q1 2026 | Mar 31, 2026 | — | May 11, 2026 | 41 d | 10-Q | — | — | -$6.95 | +66.6% | |
| FY 2025 | ||||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 13, 2026 | 72 d | 10-K | — | — | — | 9.8% | |
| Q3 2025 | Sep 30, 2025 | — | Nov 7, 2025 | 38 d | 10-Q | — | — | -$0.15 | 2.9% | |
| Q2 2025 | Jun 30, 2025 | — | Aug 13, 2025 | 44 d | 10-Q | — | — | -$15.19 | 2.4% | |
| Q1 2025 | Mar 31, 2025 | — | May 7, 2025 | 37 d | 10-Q | — | — | -$57.76 | 0.9% | |
| FY 2024 | ||||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 12, 2025 | 71 d | 10-K | $1.00K | — | — | 1.5% | |
| Q3 2024 | Sep 30, 2024 | — | Nov 12, 2024 | 43 d | 10-Q | $487.00K | +854.9% | -$73.70 | 11.6% | |
| Q2 2024 | Jun 30, 2024 | — | Aug 13, 2024 | 44 d | 10-Q | $47.00K | — | -$15.34 | — | |
| Q1 2024 | Mar 31, 2024 | — | May 14, 2024 | 44 d | 10-Q | $47.00K | — | -$1.23 | 13.9% | |
| FY 2023 | ||||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 14, 2024 | 74 d | 10-K | — | — | — | +1.4% | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | $51.00K | — | -$1.03 | — | |
| Q2 2023 | Jun 30, 2023 | — | Aug 11, 2023 | 42 d | 10-Q | — | — | -$0.85 | — | |
| Q1 2023 | Mar 31, 2023 | — | May 11, 2023 | 41 d | 10-Q | $0.00 | — | -$1.06 | — | |
| FY 2022 | ||||||||||
| Q4 2022derived | Dec 31, 2022 | Mar 20, 2023 · after-hours | Mar 20, 2023 | 79 d | 10-K | — | — | — | 1.2% | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | $0.00 | — | -$2.49 | 3.9% | |
| Q2 2022 | Jun 30, 2022 | — | Aug 11, 2022 | 42 d | 10-Q | — | — | -$1.16 | — | |
| Q1 2022 | Mar 31, 2022 | Apr 15, 2022 · after-hours | Jul 1, 2022 | 92 d | 10-Q | — | — | -$3.50 | — | |
| FY 2021 | ||||||||||
| Q4 2021derived | Dec 31, 2021 | — | Apr 15, 2022 | 105 d | 10-K | — | — | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 12, 2021 | 43 d | 10-Q | — | — | -$34.03 | — | |
| Q2 2021 | Jun 30, 2021 | — | Aug 13, 2021 | 44 d | 10-Q | — | — | -$0.24 | — | |
| Q1 2021 | Mar 31, 2021 | — | May 17, 2021 | 47 d | 10-Q | — | — | -$0.67 | — | |
| FY 2020 | ||||||||||
| Q4 2020derived | Dec 31, 2020 | — | Mar 11, 2021 | 70 d | 10-K | $1.18M | −77.3% | — | — | |
| Q3 2020 | Sep 30, 2020 | Nov 13, 2020 · pre-market | Nov 13, 2020 | 44 d | 10-Q | $1.48M | −67.8% | -$0.11 | — | |
| Q2 2020 | Jun 30, 2020 | Aug 7, 2020 · pre-market | Aug 7, 2020 | 38 d | 10-Q | $754.00K | −85.6% | -$0.12 | — | |
| Q1 2020 | Mar 31, 2020 | May 19, 2020 · after-hours | May 20, 2020 | 50 d | 10-Q | $2.39M | −50.5% | -$0.06 | — | |
| FY 2019 | ||||||||||
| Q4 2019derived | Dec 31, 2019 | Mar 17, 2020 · after-hours | Mar 19, 2020 | 79 d | 10-K | $5.17M | −12.7% | — | — | |
| Q3 2019 | Sep 30, 2019 | Oct 30, 2019 · after-hours | Nov 1, 2019 | 32 d | 10-Q | $4.58M | −23.7% | -$0.12 | — | |
| Q2 2019 | Jun 30, 2019 | Aug 9, 2019 · after-hours | Aug 12, 2019 | 43 d | 10-Q | $5.23M | −7.5% | -$0.03 | — | |
| Q1 2019 | Mar 31, 2019 | May 13, 2019 · after-hours | May 14, 2019 | 44 d | 10-Q | $4.83M | −16.1% | -$0.11 | — | |
| FY 2018 | ||||||||||
| Q4 2018derived | Dec 31, 2018 | Mar 20, 2019 · after-hours | Mar 22, 2019 | 81 d | 10-K | $5.92M | +11.8% | — | — | |
| Q3 2018 | Sep 30, 2018 | Nov 7, 2018 · after-hours | Nov 9, 2018 | 40 d | 10-Q | $6.00M | +15.5% | $0.08 | — | |
| Q2 2018 | Jun 30, 2018 | Aug 2, 2018 · after-hours | Aug 6, 2018 | 37 d | 10-Q | $5.65M | +1.8% | -$0.05 | — | |
| Q1 2018 | Mar 31, 2018 | May 9, 2018 · after-hours | May 11, 2018 | 41 d | 10-Q | $5.76M | +10.1% | -$0.16 | — | |
| FY 2017 | ||||||||||
| Q4 2017derived | Dec 31, 2017 | Mar 6, 2018 · after-hours | Mar 9, 2018 | 68 d | 10-K | $5.30M | −11.4% | — | — | |
| Q3 2017 | Sep 30, 2017 | Nov 7, 2017 · after-hours | Nov 8, 2017 | 39 d | 10-Q | $5.20M | −4.5% | -$0.07 | — | |
| Q2 2017 | Jun 30, 2017 | Aug 2, 2017 · after-hours | Aug 4, 2017 | 35 d | 10-Q | $5.55M | +2.6% | -$0.07 | — | |
| Q1 2017 | Mar 31, 2017 | May 3, 2017 · after-hours | May 4, 2017 | 34 d | 10-Q | $5.23M | −4.6% | -$0.04 | — | |
| FY 2016 | ||||||||||
| Q4 2016derived | Dec 31, 2016 | Mar 6, 2017 · after-hours | Mar 9, 2017 | 68 d | 10-K | $5.98M | −8.3% | — | — | |
| Q3 2016 | Sep 30, 2016 | Nov 8, 2016 · after-hours | Nov 9, 2016 | 40 d | 10-Q | $5.44M | −10.5% | -$0.31 | — | |
| Q2 2016 | Jun 30, 2016 | Aug 3, 2016 · after-hours | Aug 4, 2016 | 35 d | 10-Q | $5.41M | −12.7% | -$0.46 | — | |
| Q1 2016 | Mar 31, 2016 | May 6, 2016 · pre-market | May 9, 2016 | 39 d | 10-Q | $5.48M | −4.3% | -$0.57 | — | |
| FY 2015 | ||||||||||
| Q4 2015derived | Dec 31, 2015 | Mar 11, 2016 · pre-market | Mar 15, 2016 | 75 d | 10-K | $6.52M | −3.4% | — | — | |
| Q3 2015 | Sep 30, 2015 | Nov 5, 2015 · after-hours | Nov 9, 2015 | 40 d | 10-Q | $6.08M | +1.2% | -$0.73 | — | |
| Q2 2015 | Jun 30, 2015 | Aug 6, 2015 · after-hours | Aug 10, 2015 | 41 d | 10-Q | $6.19M | −9.9% | -$1.43 | — | |
| Q1 2015 | Mar 31, 2015 | May 7, 2015 · after-hours | May 8, 2015 | 38 d | 10-Q | $5.73M | −10.8% | -$0.02 | — | |
| FY 2014 | ||||||||||
| Q4 2014derived | Dec 31, 2014 | Mar 26, 2015 · after-hours | Mar 27, 2015 | 86 d | 10-K | $6.75M | +2.7% | — | — | |
| Q3 2014 | Sep 30, 2014 | Nov 6, 2014 · after-hours | Nov 7, 2014 | 38 d | 10-Q | $6.01M | +8.7% | -$0.01 | — | |
| Q2 2014 | Jun 30, 2014 | Aug 13, 2014 · after-hours | Aug 14, 2014 | 45 d | 10-Q | $6.87M | +24.2% | -$0.02 | — | |
| Q1 2014 | Mar 31, 2014 | May 14, 2014 · after-hours | May 15, 2014 | 45 d | 10-Q | $6.42M | +4.9% | -$0.01 | — | |
| FY 2013 | ||||||||||
| Q4 2013derived | Dec 31, 2013 | Mar 27, 2014 · after-hours | Mar 31, 2014 | 90 d | 10-K | $6.58M | +10.8% | — | — | |
| Q3 2013 | Sep 30, 2013 | Nov 13, 2013 · after-hours | Nov 14, 2013 | 45 d | 10-Q | $5.53M | −8.7% | $0.00 | — | |
| Q2 2013 | Jun 30, 2013 | Aug 14, 2013 · after-hours | Aug 14, 2013 | 45 d | 10-Q | $5.53M | +91,870.1% | $0.00 | — | |
| Q1 2013 | Mar 31, 2013 | May 9, 2013 · after-hours | May 13, 2013 | 43 d | 10-Q | $6.12M | +0.8% | -$0.01 | — | |
| FY 2012 | ||||||||||
| Q4 2012 | Dec 31, 2012 | Mar 28, 2013 · after-hours | Mar 29, 2013 | 88 d | 10-K | $5.93M | −2.8% | $0.01 | — | |
| Q3 2012 | Sep 30, 2012 | Nov 8, 2012 · after-hours | Nov 9, 2012 | 40 d | 10-Q | $6.05M | +3.0% | $0.00 | — | |
| Q2 2012 | Jun 30, 2012 | Aug 13, 2012 · after-hours | Aug 14, 2012 | 45 d | 10-Q | $6.02K | −0.9% | -$0.01 | — | |
| Q1 2012 | Mar 31, 2012 | May 10, 2012 · after-hours | May 11, 2012 | 41 d | 10-Q | $6.07M | +1.1% | -$0.02 | — | |
| FY 2011 | ||||||||||
| Q4 2011 | Dec 31, 2011 | Mar 29, 2012 · after-hours | Mar 30, 2012 | 90 d | 10-K | $6.10M | — | -$0.02 | — | |
| Q3 2011 | Sep 30, 2011 | — | Nov 14, 2011 | 45 d | 10-Q | $5.87M | −9.7% | -$0.01 | — | |
| Q2 2011 | Jun 30, 2011 | — | Aug 12, 2011 | 43 d | 10-Q | $6.07K | −99.9% | -$0.02 | — | |
| Q1 2011 | Mar 31, 2011 | — | May 13, 2011 | 43 d | 10-Q | $6.00M | — | -$0.01 | — | |
| FY 2010 | ||||||||||
| Q4 2010derived | Dec 31, 2010 | — | Mar 25, 2011 | 84 d | 10-K | — | — | — | — | |
| Q3 2010 | Sep 30, 2010 | — | Nov 12, 2010 | 43 d | 10-Q | $6.51M | — | $0.00 | — | |
| Q2 2010 | Jun 30, 2010 | — | Aug 13, 2010 | 44 d | 10-Q | $6.19M | — | -$0.01 | — | |
Earlier years, FY 2010 to FY 2023The latest three years
Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Source filings
Provenance
ProvenanceData status and checks
Ernexa Therapeutics Inc. · CIK 748592 · Engraved from SEC EDGAR